Abstract
This article contains first person accounts in narrative and visual form created by clients and family members who have participated in the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP). By the time most individuals join EDIPPP they have been experiencing a confusing constellation of thought and behavior changes. For most, EDIPPP signifies the next step in a journey of trying to reclaim a sense of agency in their lives and promise for the future. Understanding the process youth and families go through to make meaning of a “high risk” indication is critical for the clinicians who work with these families. By highlighting these first person accounts and the story they tell, we strive to contribute to this understanding and thereby enrich our discussion of the early detection and intervention for psychosis with the perspectives of individuals participating in our study. These narratives point to the potential value of further research focused specifically on how youth and families come to understand being at risk for psychosis.
Keywords: Adolescents, first person accounts, psychosis, schizophrenia, prodromal psychosis, high risk, recovery
Adolescent Psychiatry
Title:In the First Person: A Window into the Experience of Early Psychosis and Recovery
Volume: 2 Issue: 2
Author(s): Margaret Migliorati, Melina Salvador, Elizabeth Spring-Nichols, Sarah Lynch Tamara Sale and Steven Adelsheim
Affiliation:
Keywords: Adolescents, first person accounts, psychosis, schizophrenia, prodromal psychosis, high risk, recovery
Abstract: This article contains first person accounts in narrative and visual form created by clients and family members who have participated in the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP). By the time most individuals join EDIPPP they have been experiencing a confusing constellation of thought and behavior changes. For most, EDIPPP signifies the next step in a journey of trying to reclaim a sense of agency in their lives and promise for the future. Understanding the process youth and families go through to make meaning of a “high risk” indication is critical for the clinicians who work with these families. By highlighting these first person accounts and the story they tell, we strive to contribute to this understanding and thereby enrich our discussion of the early detection and intervention for psychosis with the perspectives of individuals participating in our study. These narratives point to the potential value of further research focused specifically on how youth and families come to understand being at risk for psychosis.
Export Options
About this article
Cite this article as:
Migliorati Margaret, Salvador Melina, Spring-Nichols Elizabeth, Tamara Sale Sarah Lynch and Adelsheim Steven, In the First Person: A Window into the Experience of Early Psychosis and Recovery , Adolescent Psychiatry 2012; 2 (2) . https://dx.doi.org/10.2174/2210676611202020146
DOI https://dx.doi.org/10.2174/2210676611202020146 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
Call for Papers in Thematic Issues
The Human Trafficking
Human trafficking, one of the darkest sides of globalization, encompasses sex-work and prostitution, as well as forced labor and domestic work. Victims include women, men, and children who may experience post-traumatic stress and depression because of sexual, psychological, and physical abuse. This special issue will examine the impact of human ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson’s and Alzheimer’s Diseases
Current Gene Therapy In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
Current Neuropharmacology nMET, A New Target in Recurrent Cancer
Current Cancer Drug Targets Novel Insight into Cholinergic Factors Associated with Schizophrenia and Autoimmunity
Current Immunology Reviews (Discontinued) Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets Strategies to In Vitro Assessment of Major Human CYP Enzyme Activities by Using Liquid Chromatography Tandem Mass Spectrometry
Current Drug Metabolism Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
Current Pharmaceutical Design BACE1 Dependent Neuregulin Processing: Review
Current Alzheimer Research Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets Novel Nucleic Acid-Based Agents: siRNAs and miRNAs
Central Nervous System Agents in Medicinal Chemistry Drug Evolution: p-Aminobenzoic Acid as a Building Block
Current Medicinal Chemistry “Bridge Proteins” Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics
Current Protein & Peptide Science EDITORIAL [Hot Topic: The Seven Biggest Risks Posed By DSM-5]
Current Psychiatry Reviews Regulation of Neuronal Cell Death and Neurodegeneration by Members of the Bcl-2 Family: Therapeutic Implications
Current Drug Targets - CNS & Neurological Disorders Evaluation of the Antipsychotic Effects of 2-(dimethylamino)- and 2-(methylamino)-7H-naphtho[1,2,3-de]quinolin-7-one Derivatives in Experimental Model of Psychosis in Mice
Current Topics in Medicinal Chemistry UCLA’s Molecular Screening Shared Resource: Enhancing Small Molecule Discovery with Functional Genomics and New Technology
Combinatorial Chemistry & High Throughput Screening Consumption of Polyphenol Plants May Slow Aging and Associated Diseases
Current Pharmaceutical Design New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5’-Phosphate Decarboxylases
Current Medicinal Chemistry Emerging Influenza Viruses: Past and Present
Current Molecular Medicine Monitoring Drug Use Among HIV/AIDS Patients in Brazil: Should we Combine Self-Report and Urinalysis?
Current HIV Research